EGFRは,AGO2のリン酸化により,低酸素への反応として,マイクロRNAの成熟を調節する
Jia Shen1, Weiya Xia, Yekaterina B Khotskaya
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.
Nature
|May 3, 2013
まとめ
表皮成長因子受容体 (EGFR) は,アルゴナウト2 (AGO2) をリン酸化することによって,低酸素期におけるマイクロRNA (miRNA) の成熟を抑制する. このEGFR-AGO2相互作用は,腫瘍細胞の生存率と侵襲性に影響を与え,潜在的な臨床的洞察を提供します.
科学分野:
- 分子生物学は分子生物学である.
- がん研究 がん研究
- 細胞のストレス反応は,
背景:
- マイクロRNA (miRNA) は,遺伝子発現の重要なポストトランスクリプションの調節体であり,その解調は癌に関与しています.
- 細胞のストレス,例えば低酸素症は,固体腫瘍では一般的ですが,ストレス下でのmiRNA生体生成の上流の調節者は不明です.
- ストレス中に腫瘍がmiRNA発現を制御する方法を理解することは,がん治療において極めて重要です.
研究 の 目的:
- 皮質成長因子受容体 (EGFR) が,低酸素ストレス下でのmiRNAの成熟を調節する役割を調査する.
- EGFRがmiRNAバイオゲネシスに影響を与える分子機構とその腫瘍進行への影響を解明する.
- 癌におけるmiRNA生殖を調節するための潜在的な治療標的を特定する.
主な方法:
- 低酸素状態でのEGFRとアルゴナウト2 (AGO2) の相互作用を調査しました.
- EGFR媒介によるAGO2リン酸化 (Tyr 393) がDicer結合とmiRNA処理に与える影響を評価した.
- miRNAの成熟を調節する前駆体miRNAのロングループ構造の役割を分析した.
- 乳がんにおける患者の生存データと相関するAGO2リン酸化レベル.
主要な成果:
- EGFRは,Tyr 393.3のAGO2リン酸化経由で低酸素状態での特定の腫瘍抑制剤のようなmiRNA成熟を抑制する.
- 低酸素はEGFR-AGO2関連性を強化し,AGO2-Y393のリン酸化を増加させ,miRNA処理を阻害する.
- 前駆ミRNAの長いループ構造は,フォスフォ-Y393-AGO2媒介ミRNAの成熟に不可欠である.
- EGFR媒介のAGO2リン酸化は,低酸素下での細胞生存と侵入性を促進し,乳がん生存率の低下と相関しています.
結論:
- EGFRは,AGO2.2の翻訳後の改変によってmiRNAの成熟を調節する新しい役割を果たします.
- EGFR媒介によるmiRNA生殖抑制は,腫瘍細胞の適応と低酸素ストレス下での生存のための重要なメカニズムです.
- EGFR-AGO2経路を標的にすることは,がん治療の新たな治療戦略を提供することができる.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

